drugset / Trial / NCT01765920
Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is: * to evaluate safety of the liquid dosage form of Ergoferon in the treatment of acute upper respiratory tract infections in adults; * to evaluate clinical efficacy of the liquid dosage form of Ergoferon in the treatment of acute upper respiratory tract infections in adults.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-12
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ergoferon | Protein / enzyme biologic | 5 ml | Oral |